The Heterogeneity of Symptom Burden and Fear of Progression Among Kidney Transplant Recipients: A Latent Class Analysis
Ying Zhang,Sainan Liu,Qi Miao,Xu Zhang,He Wei,Shuang Feng,Xiaofei Li
DOI: https://doi.org/10.2147/prbm.s454787
IF: 3.974
2024-03-18
Psychology Research and Behavior Management
Abstract:Ying Zhang, &ast Sainan Liu, &ast Qi Miao, Xu Zhang, He Wei, Shuang Feng, Xiaofei Li The First Affiliated Hospital of China Medical University, Shenyang, 110001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiaofei Li, Transplantation and Hepatobiliary Department, The First Affiliated Hospital of China Medical University, Shenyang, 110001, People's Republic of China, Tel +15940564748, Email Purpose: Kidney transplant recipients (KTRs) may experience symptoms that increase their fear of progression (FoP), but a dearth of research examines the issue from a patient-centered perspective. Our study aimed to first determine the category of symptom burden, then to explore the differences in characteristics of patients in different subgroups, and finally to analyze the impact of symptom subgroup on FoP. Patients and Methods: Sociodemographic and Clinical Characteristics, Symptom Experience Scale, and Fear of Progression Questionnaire-Short Form were used. Latent class analysis was used to group KTRs according to the occurrence of symptoms. We used multivariate logistic regression to analyze the predictors of different subgroups. The differences in FoP among symptom burden subgroups were analyzed by hierarchical multiple regression. Results: Three subgroups were identified, designated all-high (20.5%), moderate (39.9%), and all-low (39.6%) according to their symptom occurrence. Multivariate logistic regression showed that gender, post-transplant time, per capita monthly income, and hyperuricemia were the factors that distinguished and predicted the all-high subgroup ( P < 0.05). Hierarchical multiple regression showed that symptom burden had a significant effect on FoP (class1 vs class3: β = 0.327, P < 0.001; class2 vs class3: β = 0.104, P = 0.046), explaining the 8.0% variance of FoP ( ΔR 2 = 0.080). Conclusion: KTRs generally experience moderate or low symptom burden, and symptom burden is an influencing factor in FoP. Identifying the traits of KTRs with high symptom burden can help clinicians develop targeted management strategies and ease FoP of KTRs. Keywords: kidney transplant, symptom burden, fear of progression, latent class analysis Kidney transplantation (KT) can effectively improve the survival rate and quality of life of patients with end-stage renal disease (ESRD), which is an important way for ESRD patients to return to normal life. 1 China firmly secured its position as the world's second-largest country for transplants by successfully performing a staggering 12,721 KTs in 2022, according to the China Scientific Registry of Kidney Transplantation (CSRKT). KTs can effectively improve ESRD symptoms. 2 However, because of the side effects of immunosuppressive therapy and chronic rejection, kidney transplant recipients (KTRs) still experience a high symptom burden, 3 where the incidence of symptoms is as high as 79%. 4,5 In addition, related procedures during KT can lead to symptoms in the recipient. Studies have shown a high rate of ureteral stent colonization in KTRs, which in turn increases the risk of urinary tract infections. 6 Symptoms can directly or indirectly affect the health of KTRs. Studies have shown that symptoms after KT reduce quality of life, 3,7,8 affect medication compliance, 4 reduce the positive evaluation of one's health status, resulting in greater psychological pressure, 9 and can even change the outcome of transplantation. 7,10 Therefore, assessing the symptom experience of KTRs is of utmost importance to KTRs and health care professionals (HCPs) to understand disease status, disease development, and disease outcome. 11 The National Institute of Nursing Research (NINR) carried out a seminar on "Advancing Symptom Science Through Symptom Cluster Research" in 2015, which determined the strategy of symptom management centered on symptom clusters and clarified that symptom cluster management is the focus of future research. 12 Moreover, understanding symptom clusters and their internal relationships is helpful for future symptom management. 13 However, most of the current studies on symptom clusters focus on variables and carry out status research, 14 correlation research, 15 and longitudinal research. 16 This symptom clustering method quantifies symptoms and evaluates the overall symptom experience of patients but ignores the heterogeneity of individual symptom experience of patients, thus limiting the implementation of individual-centered symptom management. 17 It is worth mentioning t -Abstract Truncated-
psychology, clinical, multidisciplinary